Three Embryologists at Kanagawa Ladies Clinic Present Research Findings at “The 29th Annual Meeting of the Japanese Society of In Vitro Fertilization”
Sharing the latest research using embryo development data to support more reliable embryo selection and transfer
IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that three embryologists at Kanagawa Ladies Clinic, a clinic that receives management support from the Company, presented research findings at the 29th Annual Meeting of the Japanese Society of In Vitro Fertilization. The meeting was held at Shiroyama Hotel Kagoshima in Kagoshima City, Kagoshima Prefecture, on September 26 and 27, 2026, and the presenters were Ryosuke Suzuki, Kentaro Fujita, and Shun Yamamoto.
The Japanese Society of In Vitro Fertilization is an academic society that aims to advance research in in vitro fertilization (IVF) and related fields and to contribute to medical progress through the exchange of knowledge. Held under the theme “ART Ishin (A New Era for ART),” the 29th meeting brought together doctors, embryologists, and other professionals in reproductive medicine to share the latest research findings and clinical insights.
All three presentations reviewed embryo observation data and transfer outcomes obtained through daily embryo culture work. They examined how the course of embryo development and post-thaw handling relate to subsequent outcomes. The studies cover various stages of embryo culture, from the appearance of embryos immediately after fertilization and the dynamics of blastocysts to post-thaw culture. They are part of ongoing efforts to advance embryo assessment and culture practices on a more solid evidence base. Fujita also presented on a related topic at the international conference “ESHRE 42nd Annual Meeting” in July 2026.
In reproductive medicine, the sharing of specialized knowledge and academic collaboration, in addition to clinical experience, are becoming increasingly important. SBC Medical remains committed to advancing cutting-edge initiatives through academic activities and collaboration with research institutions, to building a more reassuring medical environment for patients, and to advancing the field of reproductive medicine.
Overview of “The 29th Annual Meeting of the Japanese Society of In Vitro Fertilization”
Dates: September 26 (Sat) and 27 (Sun), 2026
Venue: Shiroyama Hotel Kagoshima (Kagoshima City, Kagoshima Prefecture)
Official website: https://29th.ivf-et.secand.net/
Presentation Titles (in alphabetical order of presenters’ last names)
Kentaro Fujita
“Association of Cytoplasmic String Duration and Expansion Dynamics with Clinical Pregnancy”
Ryosuke Suzuki
“Effect of the Relationship Between the Pronuclear Axis and the Direction of First Cleavage on Embryo Development and Pregnancy Outcomes”
Shun Yamamoto
“Association Between Post-Thaw Recovery Culture Time and Embryo Transfer Outcomes”
About Kanagawa Ladies Clinic
Kanagawa Ladies Clinic is a clinic specializing in fertility treatment and in vitro fertilization (IVF), based in Yokohama, Kanagawa Prefecture. Under its motto of being “a casual, convenient clinic where accessibility comes first,” it provides treatment tailored to each patient’s condition and life stage. It offers a wide range of care within a highly specialized medical framework, from general fertility treatment to advanced reproductive medicine such as IVF and embryo transfer. The clinic also gives careful consideration to ease of access and the efficiency of the treatment process, working to reduce the physical, emotional, and financial burden on patients.
Official website: https://www.klc.jp/
About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp